MarketInOut Stock Screener Log In | Sign Up

Structure Therapeutics Inc ADR

IEX • Healthcare • Biotechnology • Quote as of 11/20/2026
Structure Therapeutics Inc ADR stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeIEX
Market Capitalization1,171.93 mln
Float69.46 mln
Earnings Date03/04/2027

Piotroski F-Score

2 / 9
Weak

1-Year Forecast

104.86
Transformational upside

Relative Strength

13 / 100
Significantly lagging

Debt / Equity

0.01
Debt-free

ROE

-18.36
Negative

ROA

-17.45
Deeply negative

Business Description

Structure Therapeutics is a clinical-stage pharmaceutical company focused on developing oral pill-based treatments for chronic conditions that currently lack good solutions, including obesity and lung disease. Its most advanced drug candidate, GSBR-1290, targets a key metabolic receptor and is currently being tested in two mid-stage clinical trials for obesity and related conditions. The company has several other drug programs in earlier stages of development, targeting a range of biological pathways involved in metabolism and tissue scarring. Founded in 2016 and based in South San Francisco, Structure Therapeutics operates across the United States and globally.

Key Fundamentals

EPS-3.90
ROE-18.36
ROIC-785
ROA-17.45
EBITDA, mln-210
EV / EBITDA-1.33
EV / EBIT-1.30

Quote Details

Last 16.13
Change -1.04 (-6.06%)
Open 16.73
Volume 719,440
Turnover 11,604,567
Average Volume 798,135

Financial Ratios

Leverage Ratio1.09
Current Ratio20.75
Price / Book1.13
Price / Tangible Book1.13
Debt / Equity0.01

Financial Strength

Piotroski F-Score 2 / 9
1-Year Target Price104.86
Short Ratio4.67
Short % of Float11.37

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -19.35% 11 / 100   
1 Month -26.45% 15 / 100   
2 Months -70% 4 / 100   
6 Months -58.84% 9 / 100   
1 Year -55.82% 14 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog